Name: 글로벌 시장 동향
SKU: CD2306
Availability: InStock

보고서 요약(국문)

개요
전 세계 면역단백질 진단 검사 시장은 2022년 94억 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 6.9%의 성장률로 2030년에는 158억 달러에 이를 것으로 예상됩니다.
면역단백질 진단 검사는 체내 면역단백질 수치를 측정하여 면역글로불린, 프리알부민과 같은 특정 단백질을 분석하는 진단 절차입니다. 지속적인 기술 발전으로 면역단백질 진단 검사 시장은 전 세계적으로 급성장하고 있습니다. 이러한 혁신적인 기술은 제품 수명 주기를 단축하고 시장의 범위를 확장하여 의료 분야에 다양한 기회를 창출하고 있습니다.
심혈관 질환, 암, 당뇨병, 호흡기 질환과 같은 질환은 인구 사망의 주요 원인 또는 기여 요인입니다. 이러한 만성 질환의 증가로 인해 만성 질환의 조기 진단을 위한 면역단백질 검사가 증가하고 있습니다. 면역단백질 검사는 신속한 결과를 제공하여 질환을 조기에 치료하는 데 도움을 줍니다.

또한, 기술 발전, 만성 질환 유병률 증가, 조기 질병 진단에 대한 인식 제고는 향후 시장 성장을 견인하는 요인입니다.
시장 동향
진단 검사의 발전
면역진단 검사의 발전으로 류마티스 관절염, 셀리악병 등의 질환 진단 및 치료의 정확도와 신뢰도가 향상되고 있습니다. 예를 들어, MDPI 저널에 따르면 2023년에는 미세유체 기술과 머신러닝을 결합하여 신속하고 민감하며 선택적이고 정확하며 구현이 간편한 방식으로 여러 면역 바이오마커를 대량 검출하는 기술이 개발되어, 질병의 조기 진단에 효과적으로 적용할 수 있는 첨단 현장진단(POC) 플랫폼으로 활용될 수 있었습니다.
또 다른 연구에서는 Teengam 등이 스마트폰 기반의 휴대용 면역 센싱 장치를 이용하여 HBV를 검출했으며, 임상 검체에서 HBsAg 검출 한계는 약 0.17 µg/mL였습니다. 스마트폰을 활용하는 이 저비용 전기화학 면역 센서는 높은 감도와 휴대성을 갖춘 실시간 결과를 제공할 뿐만 아니라
자가면역 질환의 증가 추세
자가면역 질환은 약 10명 중 1명꼴로 발생합니다. 자가면역 질환에는 제1형 당뇨병, 류마티스 관절염, 전신성 홍반성 루푸스, 염증성 장 질환 등이 있습니다. 이러한 질환의 부담은 개별 질환별로 증가 속도는 다르지만 시간이 지남에 따라 계속 증가하고 있습니다. 여러 자가면역 질환에서 관찰되는 사회경제적, 계절적, 지역적 불균형은 질병 발생 기전에 환경적 요인이 관여함을 시사합니다.
예를 들어, BMJ 저널에 따르면 2023년에는 전 세계 인구의 약 10%가 자가면역 질환을 앓았으며, 여성의 13%, 남성의 7%가 해당되었습니다. 2040년에는 18세 이상 미국 성인의 약 7,840만 명(25.9%)이 의사에게 관절염 진단을 받을 것으로 예상됩니다(BRFSS). 지난 수십 년 동안 주요 소아 만성 자가면역 질환의 발병률이 급격히 증가했습니다.¹ 제1형 당뇨병의 발병률은 전 세계적으로 연간 2.4%, 유럽에서는 3~4%씩 증가한 것으로 추정됩니다.
높은 진단 비용
팬데믹 이후 조기 질병 진단에 대한 수요가 증가함에 따라 진단 비용이 매일 급증하고 있습니다. 예를 들어, Scientific Electronic Library Online에 따르면 고령 메디케어 수혜자의 3분의 2가 두 가지 이상의 만성 질환을 앓고 있습니다. 이들은 전체 의료비 지출의 99%를 차지하지만, 이는 병원 합병증 위험 증가로 인해 비용이 상승하기 때문입니다. 2022년 3월부터 6월까지 6개 민간 연구소에서 제공한 IFAT 및 ELISA 키트 가격을 살펴보면, 소비자가 부담하는 샘플당 평균 최종 비용은 IFAT의 경우 30.69달러, ELISA의 경우 4.88달러로 추산됩니다. 이러한 비용은 저소득 및 중소득 국가에서 감당하기에는 너무 높습니다. 따라서 대부분의 사람들은 조기 진단을 받지 못하고 너무 늦은 말기 질환에 대해 치료를 받습니다.
세그먼트 분석
전 세계 면역단백질 진단 검사는 제품 유형, 검사 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
효소면역흡착법(ELISA) 부문은 시장 점유율의 약 35.7%를 차지했습니다.
효소면역흡착법은 정확도가 향상됨에 따라 시장 점유율이 증가할 것으로 예상됩니다. 면역진단 검사에 대한 수요 증가로 인해 신제품 출시가 늘어나고 있습니다. 예를 들어, 2022년 7월 KSL Beutner Laboratories는 만성적이고 쇠약해지는 자가면역 질환인 점막성 천포창(MMP)과 관련된 항원인 라미닌 332를 양성으로 식별하는 미국 최초의 간접 면역형광(IIF) 혈청 검사를 출시했습니다.
또한, 2023년 8월 Thermo Fisher Scientific은 EXENT 솔루션을 출시했습니다. EXENT 솔루션은 다발성 골수종을 포함한 단클론성 감마병증 환자의 진단 및 평가를 혁신적으로 개선하도록 설계된 완전 통합 자동화 질량 분석 시스템입니다. EXENT-iQ는 데이터 검토 기능을 포함한 지능적이고 직관적인 워크플로우 소프트웨어입니다.
지역 분석
북미는 2022년 시장 점유율의 약 39.3%를 차지했습니다.
북미는 만성 질환 발병률 증가와 진단 시스템에 대한 높은 수요로 인해 전 세계 면역단백질 진단 검사 시장을 주도하며 가장 큰 시장 점유율을 차지하고 있습니다. 미국 질병통제예방센터(CDC)에 따르면 만성 질환은 미국에서 사망 및 장애의 주요 원인입니다. 약 1억 3,300만 명의 미국인, 즉 인구의 45%가 하나 이상의 만성 질환을 앓고 있습니다. 만성 질환은 미국에서 발생하는 사망의 70%를 차지하며 매년 170만 명 이상의 미국인이 사망합니다.
2025년에는 만성 질환으로 고통받는 미국인이 약 1억 6,400만 명에 이를 것으로 예상됩니다. 미국에서는 만성 질환 환자들이 의료 서비스를 가장 많이 이용합니다. 높은 사망률을 낮추기 위해서는 이러한 만성 질환을 정확하고 신속하게 진단하는 것이 필수적입니다. 면역단백질 진단 기기와 시약은 만성 질환의 신속한 진단에 매우 효과적인 것으로 입증되었습니다. 미국과 캐나다의 의료 전문가들은 새로운 면역단백질 검사법 개발에 지속적으로 매진해 왔습니다.
COVID-19 영향 분석
전 세계적인 팬데믹은 인류 건강에 대한 인식을 바꾸어 놓았고, 의료 연구 업계는 새로운 의료 기술과 의약품 개발에 박차를 가하게 되었습니다. 이러한 요인은 전 세계 면역단백질 진단 시장의 성장에 긍정적인 영향을 미쳤습니다. 2019년 말 발생한 COVID-19 팬데믹은 전 세계 산업, 특히 전 세계 면역단백질 진단 검사 시장에 전례 없는 어려움을 초래했습니다. 각국은 봉쇄 조치, 공급망 차질, 경제 활동 감소에 직면했습니다.
기업들은 인플레이션 우려와 수요 약화로 투자를 줄이면서 자본 지출이 감소하는 추세를 보이고 있습니다. 성장 둔화와 인플레이션 심화로 인해 확장된 시장은 경기 침체에 진입할 것으로 예상됩니다. 새로운 코로나19 발병에 대한 우려와 중국의 불확실한 팬데믹 이후 행보는 세계 공급망에 더욱 심각한 타격을 주고 제조 차질을 초래하여 시장을 저해할 수 있는 실질적인 위험을 내포하고 있습니다.
제품 유형별
• 기기 및 키트
• 방사면역측정법
• 면역탁도측정법
• 면역단백질 전기영동법
• 효소결합면역흡착측정법
• 화학발광측정법
• 형광측정법
• 비색측정법
• 기타
• 시약
• 기타
검사 유형별
• 면역글로불린 진단 검사
• C-반응성 단백질(CRP) 진단 검사
• 보체계 단백질 진단 검사
• 유리 경쇄 진단 검사
• 합토글로빈 진단 검사
• 프리알부민 진단 검사
• 기타
적용 분야별
• 자가면역 질환 검사
• 감염성 질환 검사
• 종양학 검사
• 알레르기 검사
• 독성학 검사
• 기타
최종 사용자별
• 병원 및 클리닉
• 진단 실험실
• 외래 수술 센터
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
• 2023년 7월, Anbio의 AF-100S FIA 솔루션은 광범위한 분석 항목에 대해 신속하고 정확하며 신뢰할 수 있는 결과를 제공하는 휴대용 현장 면역 진단 솔루션입니다. Anbio AF-100S는 의료 서비스 제공자에게 광범위한 분석 항목에 대해 신속하고 정확하며 신뢰할 수 있는 결과를 제공하는 비용 효율적이고 포괄적인 솔루션을 제공하여 임상 진단 분야를 혁신하고 환자에게 더 빠른 진단과 더 나은 예후를 제공할 수 있도록 지원합니다.
• 2022년 5월, Omega Quant는 가정에서 검사할 수 있는 샘플 수집 키트가 포함된 HbA1c 검사를 출시했습니다. 이 간단하고 안전하며 편리한 검사는 혈중 당(포도당) 수치를 측정합니다.
• 미국 열대 의학 및 위생 학회(American Society of Tropical Medicine & Hygiene)는 2023년 10월 18일부터 22일까지 미국 시카고에서 연례 회의를 개최하여 연구와 실제 경험이 만나는 자리를 마련합니다. 이 회의에는 학계, 재단, 정부, 비영리 단체, 비정부 기구, 민간 부문, 군, 그리고 개인 진료 분야를 대표하는 열대 의학 및 글로벌 보건 전문가들이 참석합니다.
경쟁 환경
면역단백질 진단 검사 시장의 주요 글로벌 업체로는 Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, F. Hoffmann-La Roche Ag, Enzo Biochem, Inc, Siemens AG, Ortho Clinical Diagnostics, Diasorin S.P.A, Abcam Plc 등이 있습니다.
보고서 구매 이유

• 제품 유형, 검사 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 면역단백질 진단 검사 시장을 시각화하고 주요 상업 자산 및 주요 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 면역단백질 진단 검사 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함한 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 면역단백질 진단 검사 시장 보고서는 약 53개의 표, 54개의 그림, 195페이지 분량입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Immunoprotein Diagnostic Testing Market reached US$ 9.4 billion in 2022 and is expected to reach US$ 15.8 billion by 2030 growing with a CAGR of 6.9% during the forecast period 2023-2030.
Immunoprotein diagnostic testing is a diagnostic procedure that detects the level of immunoproteins in the body to analyze specific proteins such as immunoglobulin and pre-albumin. With continuous technological development, the immunoprotein diagnostic testing market is booming globally. These innovative technologies shorten the life cycle of a product and expand the market's boundaries, creating several medical sector opportunities.
Conditions such as cardiovascular disease, cancer, diabetes, and respiratory disease were causes or contributing factors for most of the mortality cases among the population. Due to the rise in these chronic diseases, immunoprotein testing has increased for early diagnosis of chronic diseases. These provide a rapid result, which aids in treating the condition in no time.
Furthermore, technological advancements, the increasing prevalence of chronic diseases among the population, and growing awareness about early disease diagnosis are the factors that drive the market in the forthcoming period.
Dynamics
Rising Advancements in Diagnostic Testing
Advancements in immunodiagnostic testing make the diagnosis more accurate and reliable for the treatment of diseases such as rheumatoid arthritis, celiac disease, etc. For instance, according to MDPI Journals, in 2023, the combination of microfluidic technology and machine learning effectively achieved the high-throughput detection of multiple immune biomarkers in a rapid, sensitive, selective, accurate, and easy-to-implement manner to be exploited as an advanced point-of-care (POC) detection platform for immune biomarkers effectively applicable for the early-stage diagnosis of diseases.
In another report, Teengam et al. introduced a smartphone-based portable immunosensing device for the detection of HBV, and the limit of detection was about 0.17 µg/mL of HBsAg in the clinical samples. With the use of smartphones, this low-cost electrochemical immunosensor not only provides real-time results with high sensitivity and portability
Increasing Incidence of Autoimmune Diseases
Autoimmune diseases affect about one in ten individuals. Autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease. Their burden continues to increase over time, albeit at varying rates across individual conditions. The socio-economic, seasonal, and regional disparities observed among several autoimmune disorders implicate environmental factors in disease pathogenesis.
For instance, according to BMJ journals, in 2023, autoimmune diseases affect around 10% of the global population, with 13% of women and 7% of men involved. By 2040, an estimated 78.4 million (25.9%) US adults aged 18 years or older are projected to have doctor-diagnosed arthritis (BRFSS). During the last decades, the incidence of the major pediatric chronic autoimmune diseases has increased rapidly1. Type 1 Diabetes has had an estimated annual increase of incidence of 2.4% per year worldwide and 3–4% in Europe.
High Costs of Diagnostic Tests
The cost of diagnosis is skyrocketing every day as the demand for early disease diagnosis has increased post-pandemic. For instance, according to Scientific Electronic Library Online states that two-thirds of older Medicare beneficiaries had two or more chronic conditions. They accounted for 99% of health expenditures, but the reason for this is a more heightened risk of hospital complications that increase the costs. Between March and June 2022, the prices of IFAT and ELISA kits were provided by six private laboratories. The average final cost per sample for consumers was estimated at US$ 30.69 for IFAT and US$ 4.88 for ELISA. These are too high for low and middle-income countries to afford; hence, most people skip early diagnosis and get treated for an end-stage disease when it's too late.
Segment Analysis
The global immunoprotein diagnostic testing is segmented based on product type, test type, application, end-user and region.
The Enzyme-linked immunosorbent assay Segment Accounted for Approximately 35.7% of the Market Share
Enzyme-linked immunosorbent assay is expected to increase the market share as the accuracy has increased. A rise in product launches due to the demand for immunodiagnostic testing is observed. For instance, in July 2022 KSL Beutner Laboratories launched a first-to-market Indirect Immunofluorescence (IIF) serum blood test in the US that positively identifies laminin 332, an antigen associated with the chronic, debilitating autoimmune disease mucous membrane pemphigoid (MMP).
Furthermore, in August 2023, Thermo Fisher Scientific launched the EXENT Solution. The EXENT solution is a fully integrated and automated mass spectrometry system designed to transform diagnosis and assessment for patients with monoclonal gammopathies, including multiple myeloma. EXENT-iQ, is an intelligent and intuitive workflow software, including data review.
Geographical Analysis
North America accounted for Approximately 39.3% of the Market Share in 2022
North America is dominating the global immunoprotein diagnostic testing market and accounting for the largest market share, owing to rising incidences of chronic diseases, and rising to high demand for diagnostic systems. According to the Centers for Disease Control and Prevention (CDC), chronic diseases are the leading cause of death and disability in the United States. About 133 million Americans, i.e., 45% of the population, have at least one chronic disease. Chronic diseases are responsible for seven out of every 10 deaths in the U.S., killing more than 1.7 million Americans every year.
By 2025, chronic diseases will affect an estimated 164 million Americans. People with chronic conditions are the most frequent users of health care in the U.S. Accurate and fast diagnosis of such chronic diseases is needed to help diminish the high mortality rate. Immunoprotein diagnostic devices and reagents have proven to be extremely efficacious in the rapid detection of chronic disorders. Medical practitioners in the US and Canada have continuously focused on developing new immunoprotein testing.
COVID-19 Impact Analysis
The global pandemic has changed narratives around human health, compelling the medical research industry to develop new medical technologies and drugs. This factor reflects the pandemic's positive impact on the growth of the global immunoprotein diagnostic market. The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global immunoprotein diagnostic testing market, as countries grappled with lockdowns, supply chain disruptions, and reduced economic activity
Lower capital expenditure is ongoing as businesses slow on investments, held back by inflation concerns and weaker demand. With slower growth and heightened inflation, expanded markets appear to enter a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path pose a real risk of the world experiencing more critical supply chain pain and manufacturing disruptions hindering the market.
By Product Type
• Instruments and Kits
• Radioimmunoassay
• Immunoturbidity Assay
• Immunoprotein Electrophoresis
• Enzyme-linked immunosorbent assay
• Chemiluminescence Assay
• Fluorescence Assay
• Colorimetric Assay
• Others
• Reagents
• Others
By Test Type
• Immunoglobulin Diagnostic Tests
• C-Reactive Protein (CRP) Diagnostic Tests
• Complement System Proteins Diagnostic Tests
• Free Light Chain Diagnostic Tests
• Haptoglobin Diagnostic Tests
• Prealbumin Diagnostic Tests
• Others
By Application
• Autoimmune Disease Testing
• Infectious Disease Testing
• Oncology Testing
• Allergy Testing
• Toxicology Testing
• Others
By End Users
• Hospital and clinics
• Diagnostic laboratories
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
• In July 2023, Anbio’s AF-100S FIA Solution is a handheld point-of-care immunodiagnostic solution that provides rapid, accurate, and reliable results for a wide range of analytes. The Anbio AF-100S is set to transform the field of clinical diagnostics, empowering healthcare providers with a cost-effective and comprehensive solution that provides rapid, accurate, and reliable results for a wide range of analytes to provide faster diagnosis and better prognosis to patients
• In May 2022, Omega Quant launched an HbA1c Test with a sample collection kit that allows for testing at home. This simple, safe, convenient test measures the amount of sugar (glucose) in the blood.
• American Society of Tropical Medicine & Hygiene is conducting its 2023 annual meeting in Chicago, USA from October 18-22 where research Meets real-world experience. The meeting draws tropical medicine and global health professionals representing academia, foundations, government, not-for-profit organizations, non-governmental organizations, the private sector, the military, and private practice.
Competitive Landscape
The major global players in the immunoprotein diagnostic testing market include Abbott Laboratories, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, F. Hoffmann-La Roche Ag, Enzo Biochem, Inc, Siemens AG, Ortho Clinical Diagnostics, Diasorin S.P.A, and Abcam Plc among others.
Why Purchase the Report?
• To visualize the global immunoprotein diagnostic testing market based on product type, test type, application, end-user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of immunoprotein diagnostic testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global immunoprotein diagnostic testing market report would provide approximately 53 tables, 54 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Test Type
3.3. Snippet by Technology
3.4. Snippet by Application
3.5. Snippet by End User
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Advancements in Diagnostic Testing
4.1.2. Increasing Incidence of Autoimmune Diseases
4.1.3. Restraints
4.1.3.1. High Costs of Diagnostic Tests
4.1.4. Opportunity
4.1.5. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Instruments and Kits
7.2.1. Radioimmunoassay
7.2.2. Immunoturbidity Assay
7.2.3. Immunoprotein Electrophoresis
7.2.4. Enzyme-linked immunosorbent assay
7.2.5. Chemiluminescence Assay
7.2.6. Fluorescence Assay
7.2.7. Colorimetric Assay
7.2.8. Others
7.3. Reagents
7.4. Others
8. By Test Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
8.1.2. Market Attractiveness Index, By Test Type
8.2. Immunoglobulin Diagnostic Tests
8.3. C-Reactive Protein (CRP) Diagnostic Test
8.4. Complement System Proteins Diagnostic Test
8.5. Free Light Chain Diagnostic Tests
8.6. Haptoglobin Diagnostic Tests
8.7. Prealbumin Diagnostic Tests
8.8. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By
9.1.2. Market Attractiveness Index, By Application
9.2. Autoimmune Disease Testing
9.3. Infectious Disease Testing
9.4. Oncology Testing
9.5. Allergy Testing
9.6. Toxicology Testing
9.7. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diagnostic laboratories
10.4. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.8.1. U.S.
11.2.8.2. Canada
11.2.8.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.8.1. Germany
11.3.8.2. UK
11.3.8.3. France
11.3.8.4. Italy
11.3.8.5. Russia
11.3.8.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.8.1. Brazil
11.4.8.2. Argentina
11.4.8.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.8.1. China
11.5.8.2. India
11.5.8.3. Japan
11.5.8.4. Australia
11.5.8.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Abbott Laboratories
13.1.1. Company Overview
13.1.2. Product Type Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Thermo Fisher Scientific Inc
13.3. Bio-Rad Laboratories, Inc
13.4. Danaher Corporation
13.5. F. Hoffmann-La Roche Ag
13.6. Enzo Biochem, Inc
13.7. Siemens AG
13.8. Ortho Clinical Diagnostics
13.9. Diasorin S.P.A
13.10. Abcam Plc
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Abbott Laboratories, 4.	Key Developments, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, F. Hoffmann-La Roche Ag, Enzo Biochem, Inc, Siemens AG, Ortho Clinical Diagnostics, Diasorin S.P.A, Abcam Plc

표 목록 (Tables)

List of Tables

Table 1 Global Immunoprotein Diagnostic Testing Market Value, By Product Type, 2022, 2026 & 2030 (US$ Billion)

Table 2 Global Immunoprotein Diagnostic Testing Market Value, By Test Type, 2022, 2026 & 2030 (US$ Billion)

Table 3 Global Immunoprotein Diagnostic Testing Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 4 Global Immunoprotein Diagnostic Testing Market Value, By End-User, 2022, 2026 & 2030 (US$ Billion)

Table 5 Global Immunoprotein Diagnostic Testing Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 6 Global Immunoprotein Diagnostic Testing Market Value, By Product Type, 2022, 2026 & 2030 (US$ Billion)

Table 7 Global Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 8 Global Immunoprotein Diagnostic Testing Market Value, By Test Type, 2022, 2026 & 2030 (US$ Billion)

Table 9 Global Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 10 Global Immunoprotein Diagnostic Testing Market Value, By Application, 2022, 2026 & 2030 (US$ Billion)

Table 11 Global Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 12 Global Immunoprotein Diagnostic Testing Market Value, By End-User, 2022, 2026 & 2030 (US$ Billion)

Table 13 Global Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 14 Global Immunoprotein Diagnostic Testing Market Value, By Region, 2022, 2026 & 2030 (US$ Billion)

Table 15 Global Immunoprotein Diagnostic Testing Market Value, By Region, 2021-2030 (US$ Billion)

Table 16 North America Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 17 North America Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 18 North America Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 19 North America Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 20 North America Immunoprotein Diagnostic Testing Market Value, By Country, 2021-2030 (US$ Billion)

Table 21 South America Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 22 South America Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 23 South America Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 24 South America Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 25 South America Immunoprotein Diagnostic Testing Market Value, By Country, 2021-2030 (US$ Billion)

Table 26 Europe Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 27 Europe Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 28 Europe Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 29 Europe Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 30 Europe Immunoprotein Diagnostic Testing Market Value, By Country, 2021-2030 (US$ Billion)

Table 31 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 32 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 33 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 34 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 35 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, By Country, 2021-2030 (US$ Billion)

Table 36 Middle East & Africa Immunoprotein Diagnostic Testing Market Value, By Product Type, 2021-2030 (US$ Billion)

Table 37 Middle East & Africa Immunoprotein Diagnostic Testing Market Value, By Test Type, 2021-2030 (US$ Billion)

Table 38 Middle East & Africa Immunoprotein Diagnostic Testing Market Value, By Application, 2021-2030 (US$ Billion)

Table 39 Middle East & Africa Immunoprotein Diagnostic Testing Market Value, By End-User, 2021-2030 (US$ Billion)

Table 40 Abbott Laboratories: Overview

Table 41 Abbott Laboratories: Product Portfolio

Table 42 Abbott Laboratories: Key Developments

Table 43 Thermo Fisher Scientific Inc: Overview

Table 44 Thermo Fisher Scientific Inc: Product Portfolio

Table 45 Thermo Fisher Scientific Inc: Key Developments

Table 46 Bio-Rad Laboratories, Inc: Overview

Table 47 Bio-Rad Laboratories, Inc: Product Portfolio

Table 48 Bio-Rad Laboratories, Inc: Key Developments

Table 49 Danaher Corporation: Overview

Table 50 Danaher Corporation: Product Portfolio

Table 51 Danaher Corporation: Key Developments

Table 52 F. Hoffmann-La Roche Ag: Overview

Table 53 F. Hoffmann-La Roche Ag: Product Portfolio

Table 54 F. Hoffmann-La Roche Ag: Key Developments

Table 55 Enzo Biochem, Inc: Overview

Table 56 Enzo Biochem, Inc: Product Portfolio

Table 57 Enzo Biochem, Inc: Key Developments

Table 58 Siemens AG: Overview

Table 59 Siemens AG: Product Portfolio

Table 60 Siemens AG: Key Developments

Table 61 Ortho Clinical Diagnostics: Overview

Table 62 Ortho Clinical Diagnostics: Product Portfolio

Table 63 Ortho Clinical Diagnostics: Key Developments

Table 64 Diasorin S.P.A: Overview

Table 65 Diasorin S.P.A: Product Portfolio

Table 66 Diasorin S.P.A: Key Developments

Table 67 Abcam Plc : Overview

Table 68 Abcam Plc : Product Portfolio

Table 69 Abcam Plc : Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 2 Global Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 3 Global Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 4 Global Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 5 Global Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 6 Global Immunoprotein Diagnostic Testing Market Share, By Region, 2022 & 2030 (%)

Figure 7 Global Immunoprotein Diagnostic Testing Market Y-o-Y Growth, By Product Type, 2022-2030 (%)

Figure 8 Instruments and Kits Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 9 Reagents Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 10 Others Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 11 Global Immunoprotein Diagnostic Testing Market Y-o-Y Growth, By Test Type, 2022-2030 (%)

Figure 12 Immunoglobulin Diagnostic Tests Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 13 C-Reactive Protein (CRP) Diagnostic Test Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 14 Complement System Proteins Diagnostic Test Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 15 Free Light Chain Diagnostic Tests Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 16 Haptoglobin Diagnostic Tests Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 17 Prealbumin Diagnostic Tests Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 18 Others Test Type in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 19 Global Immunoprotein Diagnostic Testing Market Y-o-Y Growth, By Application, 2022-2030 (%)

Figure 20 Autoimmune Disease Testing Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 21 Infectious Disease Testing Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 22 Oncology Testing Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 23 Allergy Testing Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 24 Toxicology Testing Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 25 Others Application in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 26 Global Immunoprotein Diagnostic Testing Market Y-o-Y Growth, By End-User, 2022-2030 (%)

Figure 27 Hospital and clinics End-User in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 28 Diagnostic laboratories End-User in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 29 Others End-User in Global Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 30 Global Immunoprotein Diagnostic Testing Market Y-o-Y Growth, By Region, 2022-2030 (%)

Figure 31 North America Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 32 Asia-Pacific Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 33 South America Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 34 Middle East and Africa Immunoprotein Diagnostic Testing Market Value, 2021-2030 (US$ Billion)

Figure 35 North America Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 36 North America Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 37 North America Immunoprotein Diagnostic Testing Market Share, By , 2022 & 2030 (%)

Figure 38 North America Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 39 North America Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 40 North America Immunoprotein Diagnostic Testing Market Share, By Country, 2022 & 2030 (%)

Figure 41 South America Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 42 South America Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 43 South America Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 44 South America Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 45 South America Immunoprotein Diagnostic Testing Market Share, By Country, 2022 & 2030 (%)

Figure 46 Europe Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 47 Europe Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 48 Europe Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 49 Europe Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 50 Europe Immunoprotein Diagnostic Testing Market Share, By Country, 2022 & 2030 (%)

Figure 51 Asia-Pacific Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 52 Asia-Pacific Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 53 Asia-Pacific Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 54 Asia-Pacific Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 55 Asia-Pacific Immunoprotein Diagnostic Testing Market Share, By Country, 2022 & 2030 (%)

Figure 56 Middle East & Africa Immunoprotein Diagnostic Testing Market Share, By Product Type, 2022 & 2030 (%)

Figure 57 Middle East & Africa Immunoprotein Diagnostic Testing Market Share, By Test Type, 2022 & 2030 (%)

Figure 58 Middle East & Africa Immunoprotein Diagnostic Testing Market Share, By Application, 2022 & 2030 (%)

Figure 59 Middle East & Africa Immunoprotein Diagnostic Testing Market Share, By End-User, 2022 & 2030 (%)

Figure 60 Abbott Laboratories: Financials

Figure 61 Thermo Fisher Scientific Inc: Financials

Figure 62 Bio-Rad Laboratories, Inc: Financials

Figure 63 Danaher Corporation: Financials

Figure 64 F. Hoffmann-La Roche Ag: Financials

Figure 65 Enzo Biochem, Inc: Financials

Figure 66 Siemens AG: Financials

Figure 67 Ortho Clinical Diagnostics: Financials

Figure 68 Diasorin S.P.A: Financials

Figure 69 Abcam Plc : Financials

글로벌 면역단백질 진단 검사 시장 – 2023-2030

Global Immunoprotein Diagnostic Testing Market - 2023-2030